| Similar Articles |
 |
Information Today November 29, 2004 Paula J. Hane |
Thomson Announces New Pharma Research Tool The Thomson Corp. is using the Online Information exhibition in London for the official launch of its new integrated research tool for the pharmaceutical and biotech industries.  |
Reactive Reports Issue 53 David Bradley |
Interview with Steve Bryant This research scientist talks about how and why PubChem was started, what it hopes to achieve, and how it is addressing some of the problems that have arisen since its inception.  |
ONLINE Sep/Oct 2007 Svetla Baykoucheva |
A New Era in Chemical Information: PubChem, DiscoveryGate, and Chemistry Central How the emergence of PubChem, DiscoveryGate and Chemistry Central are changing the field of chemical information.  |
Chemistry World December 6, 2012 Andrew Turley |
Return on drug R&D dropping The pharma industry is getting less and less return on investment in R&D, according to a report. But the trend seems to be bottoming out and -- on a more positive note -- there are more compounds going into late stage development.  |
Chemistry World October 28, 2014 Derek Lowe |
Chemical space is big. Really big. We are not going to run out of interesting and useful structures, and the uses that they could be put to are probably also beyond our imagining. In chemical space, we really do have an effectively endless frontier.  |
Chemistry World December 16, 2013 Anthony King |
Database of 15 million chemical structures set free A collection of over 15 million chemical structures from patents -- SureChem -- is to be made freely available through the European Bioinformatics Institute.  |
Chemistry World August 2009 Derek Lowe |
Column: In the pipeline The author considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder  |
Chemistry World September 11, 2014 Emma Stoye |
Pharma sales 'will reach $1 trillion' in 2014 Global sales in the pharmaceutical industry are set to go over the $1 trillion mark this year, according to a report by Thomson Reuters.  |
Information Today June 6, 2005 Miriam A. Drake |
A Cauldron Bubbles: PubChem and the American Chemical Society A freely accessible public database of chemical information, produced by a division of the U.S. National Institutes of Health (NIH), is at the center of a controversy over publicly subsidized data competing with commercial information providers.  |
Chemistry World April 25, 2013 Andreas Barth |
Chemical bibliometrics Counting compounds instead of publications and citations opens new perspectives for data-based scientific discovery and it can complement and stimulate both experimental and theoretical research.  |
Chemistry World January 20, 2014 David Bradley |
Molecular librarians create druglike collections Finding biologically active small molecules with pharmaceutical potential is a bittersweet process. Now, a new approach to building libraries of diverse alkaloid-type structures has been developed by US chemists.  |
Information Today July 18, 2013 |
Thomson Reuters Launches Company Investigator for Westlaw Next Thomson Reuters introduced a new resource for Westlaw Next users called Company Investigator, which examines private and public company structures, relationships, assets, and court documents.  |
Information Today January 4, 2010 |
Thomson Reuters Links Drug Discovery and Literature Citation Databases Thomson Reuters announced it has connected its drug discovery database, Prous Science Integrity, to Web of Knowledge, its research platform.  |
Chemistry World January 2012 |
Column: In the pipeline Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about  |
Information Today February 7, 2005 Marydee Ojala |
Dialog Divides into Sci-Tech/Intellectual Property and Business/News Parent company Thomson Corp.'s management looked at the various product lines within Dialog and decided they fell into two separate areas.  |
Chemistry World November 2011 Derek Lowe |
Column: In the Pipeline In recent years there's another class of 'unknown' compounds that's become more prominent than ever: the ones you can buy from the chemical catalogues.  |
Chemistry World October 2010 |
Column: In the pipeline Derek Lowe investigates the comeback combinatorial chemistry has made in the field of drug discovery  |
Pharmaceutical Executive January 1, 2011 Walter Armstrong |
The List It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!  |
Information Today November 25, 2002 Barbara Quint |
Tierney Resignation Sparks Management Shift at Thomson With Patrick Tierney's announced departure, Richard Harrington, Thomson's president and CEO, took the opportunity to shift the top executives in three of the four major groups that compose the giant corporation.  |
The Motley Fool November 26, 2007 Brian Lawler |
Glaxo Goes Holiday Shopping The pharmaceutical giant snaps up another acquisition, privately held Reliant Pharmaceuticals, for $1.65 billion in cash, one of the largest pharma deals of the year.  |
Information Today September 2, 2003 Barbara Quint |
Thomson Acquires Techstreet Thomson Scientific and Healthcare has acquired a new operation in a move aimed at adding the standards and specifications literature to its document delivery services.  |
Chemistry World October 2008 Derek Lowe |
Column: In the pipeline The author seeks a cure for 'compound bloat'  |
Reactive Reports Issue 62 David Bradley |
Robert Parker The appointed Managing Director of Royal Society of Chemistry Publishing discusses the future of chemistry publishing  |
Information Today February 25, 2008 |
Thomson Scientific to Use Collexis' Knowledge Dashboard in Custom Solution Plans to join Collexis' Knowledge Dashboard with Thomson Scientific's Web of Science will create a custom data mining solution for the research community.  |
Information Today March 6, 2006 |
Weekly News Digest Wiley InterScience Introduces Author Resources... Emerald Group Publishing Debuts Product to Help Community Colleges... Thomson Pharma Offers Ability to Analyze Clinical Information... etc.  |
Chemistry World June 2008 Sarah Houlton |
Breaking the rules The author finds out about some chemical tricks that can give a new drug the best possible odds of success  |
Chemistry World September 29, 2015 |
Navigating chemical space How big is chemistry? I don't mean how important is it, or how many people do it, but rather, how many molecules are there that we could make?  |
Bio-IT World August 18, 2004 Kevin Davies |
In Praise of Chemical Diversity How to build better small-molecule libraries.  |
Pharmaceutical Executive February 1, 2006 Ron Feemster |
Gene Logic: Rescue Squad One or two late-stage clinical failures can land promising drug candidates on the shelf. Forever? Maybe not. Gene Logic tests Big Pharma's dead drugs for hundreds of different targets.  |
Chemistry World April 2011 |
Column: In the Pipeline If you look over the whole pharmacopeia, you'll see there are a lot of compounds that got their start as natural products.  |
Information Today December 10, 2007 Paula J. Hane |
Thomson Scientific Launches Innovation for IP Research and Analysis Thomson Innovation is a new intellectual property research and analysis solution that integrates patent data with scientific literature and business information in a single platform that also provides analytical and workflow tools.  |
Information Today March 24, 2003 Nancy Lambert |
Thomson Opens Its Patent Store This service plans to provide a truly comprehensive patent document delivery service, with one-stop shopping for virtually all patents from any time period, anywhere in the world, and to provide it via high-speed Web access.  |
The Motley Fool June 11, 2007 Brian Lawler |
Johnson & Johnson's Pretty Pipeline While there are concerns about other parts of Johnson & Johnson (for example, its medical device segment), its pharmaceutical division has a robust pipeline of compounds in development that should pay off in the long haul.  |
Information Today March 26, 2007 |
Thomson Scientific Acquires Unleashed Informatics Thomson announced that it has acquired Unleashed Informatics, a life sciences data-management company that owns the largest repository of value-added bioinformatics records -- a significant area for target-based drug discovery.  |
Information Today July 30, 2007 |
Thomson Learning to Become Cengage Learning Thomson Learning has announced that it will change its name to Cengage Learning.  |
Chemistry World December 8, 2011 Sarah Houlton |
Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry.  |
The Motley Fool December 4, 2007 Brian Lawler |
Another Drug Deal Goes Down Canadian specialty pharma Axcan Pharma became the latest drugmaker to be acquired by a private equity group -- for $1.3 billion in cash.  |
Bio-IT World February 10, 2003 Malorye Branca |
Conquering Infinity with Chemical Genetics Harvard superchemist Stuart Schreiber defines the convergence of chemistry and biology. Now the field of chemical genetics is heading toward the clinic.  |
Information Today September 16, 2002 Barbara Quint |
Thomson Financial Launches Thomson Research Thomson Financial markets its data to research professionals and analysts at investment banks and at law, accounting, and consulting firms.  |
The Motley Fool October 11, 2004 Rich Smith |
Thomson Closes the Books The publisher successfully unloads its print media unit for a very nice price. Shareholders should be smiling.  |
Information Today April 21, 2008 |
New Combined Company--Thomson Reuters The Thomson Corp. has completed its acquisition of Reuters Group, PLC, forming Thomson Reuters, a provider of "intelligent information" for businesses and professionals in the financial, legal, tax and accounting, scientific, healthcare, and media markets.  |
Food Processing March 2009 Diane Toops |
Kraft Foods Global Thinks Outside the Box with Bioactive Ingredients Kraft hires a pharmaceutical company to help it develop functional foods.  |
T.H.E. Journal November 2004 |
Fla. Program Aids Hurricane-Ravaged Schools, Libraries The State Library and Archives of Florida and Thomson Gale have launched a collaborative program that gives those K-12 schools and public libraries damaged by the hurricanes free access to the Thomson Gale online subscription databases.  |
Chemistry World November 18, 2014 Katrina Kramer |
Molecules: the elements and the architecture of everything Molecules is a serious attempt to explain the world of chemical compounds to the reader without assuming previous science knowledge.  |
The Motley Fool June 29, 2004 Rich Smith |
Thomson's Patently Good Buy Thomson will purchase Information Holdings, a provider of intellectual property information. The acquisition would significantly boost Thomson's scientific and health-care business.  |
Information Today January 22, 2007 Barbara Quint |
Thomson Business Intelligence Dismantling Thomson Business Intelligence, created from a 2005 reorganization of assets previously assigned to Dialog and reporting to Thomson Legal & Regulatory, has begun dismantling its operations and disposing of its products.  |
Information Today October 29, 2015 |
Thomson Reuters Streamlines Healthcare Industry Analysis Thomson Reuters rolled out the Healthcare Intelligence application for Thomson Reuters Eikon to improve workflow for financial professionals.  |
The Motley Fool April 26, 2006 Rich Smith |
Foolish Forecast: Thomson's Numbers Why does Thomson emphasize its free cash flow production rather than its reported earnings under generally accepted accounting principles (GAAP)? Investors, take note.  |
The Motley Fool November 2, 2004 Rich Smith |
Thomson Prints Profits The Canadian megapublisher offers high quality at full price.  |
The Motley Fool February 8, 2006 Rich Smith |
Foolish Forecast: Thomson Publishes Unless cash generation surged in the fourth-quarter, 2005 will probably have to go down in the record books as a pretty weak year for Thomson. Investors, take note.  |